Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccine for glycemic control in pediatric type 1 diabetes
IRCT20201012049003N1Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bcg vaccine in diabetes mellitus type 1 (T1D), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: HbA1c, fasting blood sugar and 8 more. Started Oct 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on IRCT20201012049003N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201012049003N1.